Brief: Palatin To Present Dry Eye Disease Clinical Data Results
08/04/2024 12:43
April 8 (Reuters) - Palatin Technologies Inc PTN.A :
* PALATIN ANNOUNCES PHASE 3 PL9643 MELODY-1 DRY EYE DISEASE
(DED)
CLINICAL DATA RESULTS PRESENTED AT AMERICAN SOCIETY OF CATARACT
AND REFRACTIVE SURGERY (ASCRS) 2024
Source text for Eikon: ID:nPn27gZwva
Further company coverage: PTN.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palatin Technologies
See all newsPalatin Technologies Inc reports results for the quarter ended March 31 - Earnings Summary
Palatin Technologies Inc expected to post a loss of $1.20 a share - Earnings Preview
Palatin Technologies Q2 revenue rises yr/yr, net loss widens
Brief: Palatin Announces 1-For-50 Reverse Stock Split
Brief: Palatin Announces Positive Preclinical Efficacy Data For Oral MC4R Agonist PL7737 In Animal Model Of Obesity